Goldberg SB, Redman MW, Lilenbaum R, Politi K, et al. Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line
Treatment of EGFR-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG
S1403. J Clin Oncol 2020 Oct 6:JCO2001149. doi: 10.1200/JCO.20.01149.
PMID: 33021871